US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sandridge Energy Inc.

9.29

+0.18001.98%

Volume:280.01K

Turnover:2.60M

Market Cap:344.59M

PE:5.50

High:9.42

Open:9.11

Low:9.11

Close:9.11

Loading ...

Overview Company News Filings

Press Release: Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update

Republic of Gamers Announces Next-Gen RTX 50 Series Laptop Lineup – Now Available for Pre-Order in Canada

SandRidge Energy (NYSE:SD) shareholders have earned a 47% CAGR over the last five years

Simply Wall St.

Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases

SD Guthrie's Marvesa 48% Stake Buy Could Strengthen Downstream Business -- Market Talk

Aurora among best-positioned in SD truck industry, says Cantor Fitzgerald

Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer

GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy

Create SD Holdings 1H Net Y7.02B Vs Net Y6.88B

Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria

BioInvent Announces Promising Initial Efficacy Data from Triple Combination Arm of BI-1206, Rituximab and Calquence for the Treatment of non-Hodgkin's Lymphoma

BioInvent Announces Promising Data for BI-1910 as Single Agent from Phase 1 Study in Solid Tumors

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

SandRidge Energy Up Nearly 7%, on Pace for Largest Percent Increase Since June 2023 -- Data Talk

S&P Affirms Sri Lanka's SD/SD, CCC+/C Ratings on Completion of Distressed Debt Exchange

MT Newswires Live

SD Guthrie's Industrial Park JV Looks Like a Good Way to Diversify Revenue -- Market Talk

SandRidge Energy, Inc.'s (NYSE:SD) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Simply Wall St.

Higher Oil Prices in the Future Could Boost SandRidge Energy’s (SD) Deal

Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial

Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analysis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SD/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SD\",,,,,undefined,":{"symbol":"SD","market":"US","secType":"STK","nameCN":"Sandridge Energy Inc.","latestPrice":9.29,"timestamp":1746129600000,"preClose":9.11,"halted":0,"volume":280007,"delay":0,"floatShares":36549742,"shares":37092231,"eps":1.69,"marketStatus":"Pre-Mkt","change":0.18,"latestTime":"05-02 05:39:10 EDT","open":9.11,"high":9.42,"low":9.11,"amount":2604419.3088550004,"amplitude":0.034029,"askPrice":14.86,"askSize":200,"bidPrice":8.49,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.69,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746192600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1475553600000,"exchange":"NYSE","adjPreClose":9.29,"dividendRate":0.047363,"postHourTrading":{"tag":"盘后","latestPrice":9.29,"preClose":9.29,"latestTime":"16:47 EDT","volume":7494,"amount":69604.57,"timestamp":1746132464417},"volumeRatio":1.1227684526103812,"impliedVol":0.6892,"impliedVolPercentile":0.9558},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SD\",,,,,undefined,":{"symbol":"SD","floatShares":36549742,"roa":"3.65%","roe":"13.57%","lyrEps":1.697461,"volumeRatio":1.1227684526103812,"shares":37092231,"dividePrice":0.44,"high":9.42,"amplitude":0.034029,"preClose":9.11,"low":9.11,"week52Low":8.81,"pbRate":"0.75","psRate":"2.75","week52High":14.24,"institutionHeld":0,"latestPrice":9.29,"committee":-0.333333,"eps":1.69,"divideRate":0.047363,"volume":280007,"delay":0,"ttmEps":1.69,"open":9.11,"prevYearClose":11.71,"prevWeekClose":9.52,"prevMonthClose":9.11,"prevQuarterClose":11.42,"fiveDayClose":9.36,"twentyDayClose":11.38,"sixtyDayClose":12.14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SD\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514080445","title":"Press Release: Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514080445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514080445?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update. \"The past year has been a transformational period for Jasper, highlighted by positive data readouts from the BEACON study in CSU and the SPOTLIGHT study in CIndU, our first two clinical studies evaluating Briquilimab in mast cell diseases,\" said Ronald Martell, President and Chief Executive Officer of Jasper. \"Data from both studies demonstrate the ability of briquilimab to drive rapid and deep response profiles in patients with chronic urticaria, along with the potential for a favorable and differentiated safety profile. We believe the preliminary results from the BEACON study support advancing briquilimab into a pivotal program in CSU beginning with an operationally adaptive Phase 2b study that we expect to commence later this year. Final dose selection for the Phase 2b study will be further informed by a substantial array of additional clinical data at doses of 180mg and hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4161","PR","CR","SD","JSPR","BK4213","BK4139"],"gpt_icon":0},{"id":"2514217880","title":"Republic of Gamers Announces Next-Gen RTX 50 Series Laptop Lineup – Now Available for Pre-Order in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2514217880","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514217880?lang=en_us&edition=fundamental","pubTime":"2025-02-26 08:51","pubTimestamp":1740531060,"startTime":"0","endTime":"0","summary":"ROG continues to set the standard of gaming with its powerful laptop lineup equipped with NVIDIA RTX 50 Series of GPU's TORONTO, Feb.  25, 2025  (GLOBE NEWSWIRE) -- ASUSRepublic of Gamers(ROG) announc","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032519/0/en/Republic-of-Gamers-Announces-Next-Gen-RTX-50-Series-Laptop-Lineup-Now-Available-for-Pre-Order-in-Canada.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","GEN","IE0009G5SDU7.USD","LU0289941410.SGD","LU1633808545.USD","SDR","LU1721428933.USD","LU2250418816.HKD","LU1914381329.SGD","LU1043141123.HKD","IE000ITXATA3.USD","NVDD","LU1043141396.HKD","LU2430703178.SGD","BK4581","NVDS","BK4535","LU2191332357.HKD","LU1066051498.USD","NVDS.UK","LU1880398471.USD","NVD3.UK","NVDY","LU0312595415.SGD","2NVD.UK","NVDA","SD","NVD2.UK","NVDU","SNVD.UK","LU1935042991.SGD","LU1974910355.USD","LU2065169927.USD","LU0079474960.USD","3NVD.UK","RTX","NVIW.SI","LU0889566641.SGD","LU2506952170.USD","NVDX","IE00BN8TJ469.HKD","ROG","LU2403377893.USD","LU1506573853.SGD","NVD","LU1839511570.USD"],"gpt_icon":1},{"id":"2511696727","title":"SandRidge Energy (NYSE:SD) shareholders have earned a 47% CAGR over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696727","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511696727?lang=en_us&edition=fundamental","pubTime":"2025-02-14 22:31","pubTimestamp":1739543501,"startTime":"0","endTime":"0","summary":"We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs well, when investors win, they can win big. Just think about the savvy investors who held SandRidge Energy, Inc.  shares for the last five years, while they gained 424%. This just goes to show the value creation that some businesses can achieve. In the last week the share price is up 2.1%.With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sandridge-energy-nyse-sd-shareholders-143141355.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NYSE","BK4213","SD"],"gpt_icon":0},{"id":"2509731232","title":"Tonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2509731232","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509731232?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:00","pubTimestamp":1738846800,"startTime":"0","endTime":"0","summary":"Results from the Phase 1 single ascending dose study support proceeding to develop a Phase 2 trial for the prevention of kidney transplant rejection TNX-1500 blocked the primary and secondary antibody","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/06/3021973/28908/en/Tonix-Pharmaceuticals-Announces-Positive-Topline-Results-from-Phase-1-Trial-for-TNX-1500-a-Next-Generation-anti-CD40L-mAb-Candidate-for-Prevention-of-Kidney-Transplant-Rejection-an.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","CNS","TNXP","BK4139","SD","BK4135","BK4583"],"gpt_icon":1},{"id":"2508106662","title":"SD Guthrie's Marvesa 48% Stake Buy Could Strengthen Downstream Business -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2508106662","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508106662?lang=en_us&edition=fundamental","pubTime":"2025-02-04 10:19","pubTimestamp":1738635540,"startTime":"0","endTime":"0","summary":"0219 GMT - SD Guthrie's Marvesa 48% stake acquisition looks set to help strengthen its downstream business expansion, diversify into other soft oils and boost trading between Europe and Asia-Pacific, MIDF Research says in a note. The 250 million ringgit acquisition comes as a surprise, particularly as many of the company's peers have adopted a cautious stance toward the region due to the impending European Union deforestation regulation policy, it notes. However, considering the plantation giant's strong supply-chain credentials, SD Guthrie views Europe as a key growth driver, MIDF says. SD Guthrie's balance sheet remains healthy and is well-positioned for expansion, it adds. MIDF maintains a buy rating on SD Guthrie and keeps its target price at MYR5.43. Shares are 0.6% higher at MYR4.88. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SD"],"gpt_icon":0},{"id":"2506742093","title":"Aurora among best-positioned in SD truck industry, says Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2506742093","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506742093?lang=en_us&edition=fundamental","pubTime":"2025-01-27 21:16","pubTimestamp":1737983771,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Andres Sheppard, in a research note to investors, said that Aurora Innovation (AUR) released its driverless operations re...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aurora-among-best-positioned-in-sd-truck-industry-says-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aurora-among-best-positioned-in-sd-truck-industry-says-cantor-fitzgerald?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","BK4023","AUR","SD","ACB","BK4557","BK4137","BK4007"],"gpt_icon":0},{"id":"2505278023","title":"Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505278023","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505278023?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:01","pubTimestamp":1737496860,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Jan. 21, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc.  , a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced preliminary efficacy and safety data from the Phase 1 trial of ozekibart  in combination with FOLFIRI for the treatment of advanced or metastatic, unresectable colorectal adenocarcinoma . These results were presented at the American Society of Clinical Oncology  Gastrointestinal Annual Cancers Symposium.Ozekibart-related treatment-emergent adverse events  were reported in 84.6% of patients, with most being grade 1 or 2 in severity. Grade ≥3 TEAEs were observed in 30.8% of patients. The most common ozekibart-related TEAEs included nausea, increased alanine aminotransferase, diarrhea, and fatigue, with the majority being low-grade.Ozekibart is a precision-engineered, tetravalent death receptor 5  agonist antibody designed to exploit the tumor-biased cell death induced by DR5 activation.In Januar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/inhibrx-biosciences-announces-preliminary-data-220100477.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inhibrx-biosciences-announces-preliminary-data-220100477.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0266512127.USD","LU0456854461.SGD","BK4195","BK4139","INBX","SD","BK4211","BK4161","CR","BK4213","PR","CRC","PFS"],"gpt_icon":0},{"id":"2503664365","title":"GenSight Biologics Announces Publication of 5-Year Outcomes for Patients Treated Unilaterally with LUMEVOQ® Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2503664365","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503664365?lang=en_us&edition=fundamental","pubTime":"2025-01-15 14:30","pubTimestamp":1736922600,"startTime":"0","endTime":"0","summary":"Five years after the one-time injection, patients with Leber Hereditary Optic Neuropathy  due to the MT-ND4 gene variant demonstrated sustained bilateral improvement in visual acuity and favorable safety profile.The RESTORE study provides the first long-term benefit-risk assessment of gene therapy in LHON from a Phase III study.GenSight Biologics , a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the publication of outcomes data from five years’ follow-up of patients treated unilaterally with LUMEVOQ, the company’s investigational gene therapy for Leber Hereditary Optic Neuropathy  due to a mutated ND4 mitochondrial gene. The patients had all participated in the Phase III trials RESCUE and REVERSE and accepted enrolling into the long-term study RESTORE at the end of the RESCUE and REVERSE studies.Table 1. Change in BCVA Vs. Nadir* In LUMEVOQ Long-Term Foll","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gensight-biologics-announces-publication-5-063000499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GSGTF","BK4213","SD","BK4139"],"gpt_icon":0},{"id":"2503463515","title":"Create SD Holdings 1H Net Y7.02B Vs Net Y6.88B","url":"https://stock-news.laohu8.com/highlight/detail?id=2503463515","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503463515?lang=en_us&edition=fundamental","pubTime":"2025-01-14 14:32","pubTimestamp":1736836320,"startTime":"0","endTime":"0","summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SD","BK4213"],"gpt_icon":0},{"id":"2501725330","title":"Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria","url":"https://stock-news.laohu8.com/highlight/detail?id=2501725330","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501725330?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:00","pubTimestamp":1736337600,"startTime":"0","endTime":"0","summary":"Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile Mean change in UAS7 from baseline of -26.6 observed in the 240mg single dose ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/08/3006120/0/en/Jasper-Therapeutics-Reports-Positive-Data-from-BEACON-Study-of-Briquilimab-in-Chronic-Spontaneous-Urticaria.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","JSPR","BK4139","SD"],"gpt_icon":0},{"id":"2501719058","title":"BioInvent Announces Promising Initial Efficacy Data from Triple Combination Arm of BI-1206, Rituximab and Calquence for the Treatment of non-Hodgkin's Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2501719058","media":"ACCESSWIRE","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501719058?lang=en_us&edition=fundamental","pubTime":"2025-01-08 15:20","pubTimestamp":1736320800,"startTime":"0","endTime":"0","summary":"LUND, SWEDEN / ACCESSWIRE / January 8, 2025 / BioInvent International . The first two patients enrolled in the Phase 2a study triplet arm combining BI-1206 with rituximab and Calquence responded to treatment. The preliminary data demonstrates that the combination treatment is well tolerated with the two enrolled patients already showing clinical responses. One patient has obtained a complete response , and one patient shows a partial response . Patient enrollment remains on schedule. Further Phase 2a data are expected by mid-2025.In addition, the Phase 1/2a study of BI-1206 in combination with MSD's  anti-PD-1 therapy KEYTRUDA  in heavily pre-treated patients with solid tumors continues to progress. The subcutaneous administration of BI-1206 has been well-tolerated with no notable injection reactions. Given the beneficial safety and tolerability profile observed to date, an additional dose cohort with increased dose frequency has been added to the Phase 1 part to further characterize t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioinvent-announces-promising-initial-efficacy-072000078.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1037948897.HKD","CR","LU0203345920.USD","LU1061106388.HKD","LU0234572021.USD","MRK","LU0211331839.USD","LU0861579265.USD","PR","LU0965509283.SGD","SG9999015358.SGD","LU2023250843.SGD","LU1699723380.USD","LU0070302665.USD","IE0009355771.USD","IE00BMPRXR70.SGD","IE00BMPRXQ63.HKD","LU1066051811.HKD","LU0208291251.USD","LU2461242641.AUD","LU1934455194.USD","LU0265550359.USD","SG9999014575.USD","IE000M9KFDE8.USD","LU0122379950.USD","BOVNF","IE0002141913.USD","LU1066051498.USD","LU1291159041.SGD","LU1571399168.USD","LU1983299246.USD","SG9999014559.SGD","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0289739699.SGD","LU1037948541.HKD","SG9999002224.SGD","LU0965509101.SGD","LU1116320737.USD","LU2468319806.SGD","LU1585245621.USD","SD","LU1917777945.USD","IE00B1BXHZ80.USD","LU1989772923.USD","BK4007","SG9999015341.SGD","LU0006306889.USD"],"gpt_icon":1},{"id":"2501050719","title":"BioInvent Announces Promising Data for BI-1910 as Single Agent from Phase 1 Study in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2501050719","media":"ACCESSWIRE","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501050719?lang=en_us&edition=fundamental","pubTime":"2025-01-08 15:20","pubTimestamp":1736320800,"startTime":"0","endTime":"0","summary":"LUND, SWEDEN / ACCESSWIRE / January 8, 2025 / BioInvent International . BI-1910 single agent Phase 1 Part A dose escalation has been completed and reached a biologically active dose level. Data show stable disease as best clinical response with no notable adverse events even at the highest doses tested.Phase 1 part B evaluating BI-1910 in combination with MSD's anti-PD-1 therapy, KEYTRUDA  initiated. As reported in September 2024, preliminary results from the BI-1808 monotherapy study showed that three out of four evaluable patients achieved partial response  in the CTCL cohort of patients who had progressed after standard therapy. These responses are currently ongoing and deepening. New clinical sites have been opened and the enrollment rate in this c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioinvent-announces-promising-data-bi-072000027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211331839.USD","LU1066051498.USD","LU1699723380.USD","LU0965509101.SGD","SG9999015341.SGD","LU0070302665.USD","SG9999014559.SGD","LU0208291251.USD","LU1585245621.USD","BK4516","IE0002141913.USD","LU0861579265.USD","LU1066051811.HKD","LU1116320737.USD","LU1037948897.HKD","LU0965509283.SGD","BOVNF","LU1983299246.USD","LU1989772923.USD","LU1934455194.USD","BK4007","LU0203345920.USD","LU0234572021.USD","LU0265550359.USD","LU1934455277.USD","LU0965509010.AUD","LU0289739699.SGD","LU1571399168.USD","MRK","IE000M9KFDE8.USD","LU1291159041.SGD","SG9999002224.SGD","IE00B4R5TH58.HKD","BK4585","IE0009355771.USD","SD","SG9999014575.USD","LU0006306889.USD","IE00B1BXHZ80.USD","SG9999015358.SGD","PR","LU1023059063.AUD","LU1037948541.HKD","LU1061106388.HKD","CR","LU1917777945.USD","LU0122379950.USD","LU2023250843.SGD","LU2461242641.AUD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2501373028","title":"Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2501373028","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501373028?lang=en_us&edition=fundamental","pubTime":"2025-01-08 05:05","pubTimestamp":1736283900,"startTime":"0","endTime":"0","summary":"The study is the largest to date evaluating clinical outcomes of standalone canaloplasty and trabeculotomy. It analyzes real-world data from the American Academy of Ophthalmology IRIS Registry and dem","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/07/3005847/0/en/Sight-Sciences-Announces-Real-World-36-Month-Study-Confirming-Long-Term-Effectiveness-of-Standalone-OMNI-Surgical-System-in-Managing-Primary-Open-Angle-Glaucoma.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4539","SD","SGHT","BK4213"],"gpt_icon":0},{"id":"2495743975","title":"SandRidge Energy Up Nearly 7%, on Pace for Largest Percent Increase Since June 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2495743975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495743975?lang=en_us&edition=fundamental","pubTime":"2024-12-31 03:06","pubTimestamp":1735585560,"startTime":"0","endTime":"0","summary":"SandRidge Energy, Inc.  is currently at $11.51, up $0.75 or 6.97%. --Would be highest close since Dec. 3, 2024, when it closed at $11.64. --On pace for largest percent increase since June 29, 2023, when it rose 9.95%. --Down 1.88% month-to-date; on pace for worst month since Oct. 2024, when it fell 9.32%. --Down 59.41% from its all-time closing high of $28.36 on June 7, 2022. --Down 15.80% from 52 weeks ago , when it closed at $13.67. --Down 23.88% from its 52-week closing high of $15.12 on April 3, 2024. --Up 9.62% from its 52-week closing low of $10.50 on Dec. 23, 2024. --Traded as high as $11.65; highest intraday level since Dec. 4, 2024, when it hit $11.67. --Up 8.27% at today's intraday high; largest intraday percent increase since June 29, 2023, when it rose as much as 10.53%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SD"],"gpt_icon":0},{"id":"2495591280","title":"S&P Affirms Sri Lanka's SD/SD, CCC+/C Ratings on Completion of Distressed Debt Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2495591280","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495591280?lang=en_us&edition=fundamental","pubTime":"2024-12-30 15:41","pubTimestamp":1735544517,"startTime":"0","endTime":"0","summary":"S&P Global Ratings maintained Sri Lanka's selective default  long- and short-term foreign currency and CCC+/C long- and short-term local currency sovereign credit ratings, according to a Friday release.The rating agency also placed CCC+ ratings on some of the country's newly issued sovereign bonds.The rating actions come as Sri Lanka finished the distressed debt exchange of most of its $12.55 billion in outstanding international sovereign bonds in place of the new notes.Bondholders accounting for 97.8% of the total outstanding bonds agreed to the exchange offer, which is expected to result in about $9.5 billion in debt service payment reduction, among other relief.However, the government is still in the process of restructuring a $175 million bond it guarantees, which is still in default.The long-term foreign currency rating outlook is stable, with improvements in the country's debt profile due to the restructuring balancing fiscal risks from economic and fiscal pressures in the next 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SD"],"gpt_icon":0},{"id":"2492319863","title":"SD Guthrie's Industrial Park JV Looks Like a Good Way to Diversify Revenue -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2492319863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492319863?lang=en_us&edition=fundamental","pubTime":"2024-12-19 09:36","pubTimestamp":1734572160,"startTime":"0","endTime":"0","summary":"0135 GMT - SD Guthrie's industrial park joint venture with Eco World Development in Malaysia could be a significantly strategic way to diversify revenue streams, MIDF Research says in a note. The project is expected to contribute to the planter's earnings over the medium to long term, the research house says. With a low gearing ratio of 0.25X as of 3Q--below the property sector average of 0.4X--SD Guthrie appears financially well-placed to pursue new income-generating opportunities, it reckons. MIDF maintains a buy rating on SD Guthrie with a MYR5.43 target price. Shares are 0.2% lower at MYR4.91. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SD"],"gpt_icon":0},{"id":"2490384852","title":"SandRidge Energy, Inc.'s (NYSE:SD) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490384852","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490384852?lang=en_us&edition=fundamental","pubTime":"2024-12-12 19:46","pubTimestamp":1734004010,"startTime":"0","endTime":"0","summary":"It is hard to get excited after looking at SandRidge Energy's  recent performance, when its stock has declined 3.8% over the past month. However, stock prices are usually driven by a company’s financials over the long term, which in this case look pretty respectable. Specifically, we decided to study SandRidge Energy's  ROE in this article.Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.Return on equity can be calculated by using the formula:. Return on Equity = Net Profit  ÷ Shareholders' Equity. So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or \"retains\" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zbingGm8u8WvxKzb7gFJEQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fef15a04bcb8e7f05d317d73670619f7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zbingGm8u8WvxKzb7gFJEQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/fef15a04bcb8e7f05d317d73670619f7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sandridge-energy-inc-nyse-sd-114650734.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","NYSE","SD"],"gpt_icon":0},{"id":"2490026048","title":"Higher Oil Prices in the Future Could Boost SandRidge Energy’s (SD) Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2490026048","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490026048?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:08","pubTimestamp":1733839736,"startTime":"0","endTime":"0","summary":"Seven Corners Capital, an investment management company, released its Q3 2024 investor letter. A copy of the letter can be downloaded here. Seven Corners Capital's composite portfolio finished Q3 2024 increasing around 14%, while the S&P 500 increased by approximately 21%. This represents a 7% underperformance in the first half of the year. Since 2020 , the SCC Composite Portfolio has increased by ~127% compared to ~79% for the S&P 500, including all dividends received. This is an outperformance of 4,800 basis points compared to the index. In addition, you can check the fund’s top 5 holdings to know its best picks in 2024..SandRidge Energy, Inc.  is not on our list of31 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held SandRidge Energy, Inc.  at the end of the third quarter which was 16 in the previous quarter. While we acknowledge the potential of SandRidge Energy, Inc.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/tJ3c36T93qc6NyY8cyxe3A--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e5854a4ac4fa47d2e6c25427e4bd727a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/tJ3c36T93qc6NyY8cyxe3A--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e5854a4ac4fa47d2e6c25427e4bd727a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/higher-oil-prices-future-could-140856514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SD","BK4213"],"gpt_icon":0},{"id":"2490772771","title":"Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2490772771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490772771?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:45","pubTimestamp":1733751900,"startTime":"0","endTime":"0","summary":"The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at any dose level Stable disease (SD) at four months post-in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/09/2993772/0/en/Sonnet-BioTherapeutics-Announces-Topline-Safety-Data-Following-Successful-Completion-of-SON-1010-Monotherapy-Dose-Escalation-in-Phase-1-SB101-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2413666699.HKD","BK4533","BK4136","LU1169590202.USD","01698","LU0359202008.SGD","PD","BK4181","IE00BYTNYN87.SGD","SG9999011746.SGD","LU0359201612.USD","IE00BYQNZ168.SGD","IE00B12V2V27.USD","PR","BK4218","LU0347712357.USD","SON","BK4563","LU1169589451.USD","LU1023057109.AUD","BK4007","BK4535","BK4023","SONN","BK4548","BK4567","LU1093756168.USD","LU2039709279.SGD","BK4552","BK4571","BK4526","BK4588","SD","LU2413666426.HKD","BK4108","LU1093756325.SGD","BK4121","BK4139","BK4213","BK4565","BK4585","BK4531","PK","MTD","PROC","TME","BK4509","LU1721428933.USD"],"gpt_icon":0},{"id":"2489242393","title":"Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2489242393","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489242393?lang=en_us&edition=fundamental","pubTime":"2024-12-06 10:15","pubTimestamp":1733451300,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan showed a 42.7% objective response rate in previously treated patients. Data support recent BLA submission in the U.S. for this patient population. TOKYO & BASKING RIDGE, N.J., December 06, 2024----A pooled analysis of the TROPION-Lung05 phase 2 and the TROPION-Lung01 phase 3 trials showed datopotamab deruxtecan  demonstrated clinically meaningful tumor response in patients with previously treated advanced or metastatic EGFR-mutated non-small cell lung cancer . These data, along with progression-free and overall survival results from the analysis, were presented during a late-breaking proffered paper session  at the 2024 ESMO Asia  Congress.Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate  discovered by Daiichi Sankyo  and being jointly developed by Daiichi Sankyo and AstraZeneca .The safety profile of datopotamab deruxtecan was consistent with previous reports from the TROPION-Lung05 a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/FFFV0HSQ0rhQXmzy7suhMQ--~B/aD00NzQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fca47f2662fc4f675cc4545678bdaa58","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/FFFV0HSQ0rhQXmzy7suhMQ--~B/aD00NzQ7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fca47f2662fc4f675cc4545678bdaa58"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/datopotamab-deruxtecan-demonstrated-meaningful-clinical-021500818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4213","IE00B66KJ199.SGD","ADC","BK4097","PFS","IE00B19Z4B17.USD","DSKYF","AEIS","PBD","OS","IE00B7SZL793.SGD","BK4211","DSNKY","BK4007","BK4179","IE0031619046.USD","AESI","BK4231","BK4195","BK4157","SD"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":94,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SD\",params:#limit:5,,,undefined,":[{"date":"2025-03-20","symbol":"SD","amount":0.11,"announcedDate":"2025-03-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-20","defaultRemindTime":1742477400000,"name":"SandRidge Energy","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-31","payableDate":"2025-03-20","currency":"USD","dateTimestamp":1742443200000,"payDate":"2025-03-31"},{"market":"US","date":"2025-03-10","symbol":"SD","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741579200000,"reportTimeType":"pre","actualEps":0.34},{"date":"2024-11-15","symbol":"SD","amount":0.11,"announcedDate":"2024-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-15","defaultRemindTime":1731681000000,"name":"SandRidge Energy","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-29","payableDate":"2024-11-15","currency":"USD","dateTimestamp":1731646800000,"payDate":"2024-11-29"},{"market":"US","date":"2024-11-06","symbol":"SD","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":0.19},{"date":"2024-08-16","symbol":"SD","amount":0.11,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-16","defaultRemindTime":1723815000000,"name":"SandRidge Energy","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-30","payableDate":"2024-08-16","currency":"USD","dateTimestamp":1723780800000,"payDate":"2024-08-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SD\",market:\"US\",,,undefined,":[{"executeDate":"2023-05-23","recordDate":"2023-05-24","paymentDate":"2023-06-07","value":2,"currency":"USD"},{"executeDate":"2023-08-11","recordDate":"2023-08-14","paymentDate":"2023-08-28","value":0.1,"currency":"USD"},{"executeDate":"2023-11-10","recordDate":"2023-11-13","paymentDate":"2023-11-27","value":0.1,"currency":"USD"},{"executeDate":"2024-02-02","recordDate":"2024-02-05","paymentDate":"2024-02-20","value":1.5,"currency":"USD"},{"executeDate":"2024-03-14","recordDate":"2024-03-15","paymentDate":"2024-03-29","value":0.11,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1722657600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SD","date":"2025-05-01","current":5.364847,"percent":0.647681,"low":-1.152579,"twenty":-0.101479,"median":3.665522,"eighty":8.933445,"high":209.684554,"avg":12.690174,"sd":37.643861,"marketCap":337910224},"quantilePoints":[{"date":"2020-05-08","current":-0.148735,"twenty":-3.117561,"median":-0.220786,"eighty":1.575586,"marketCap":66827408},{"date":"2020-05-15","current":-0.11788,"twenty":-3.04097,"median":-0.220027,"eighty":1.575586,"marketCap":52964276},{"date":"2020-05-22","current":-0.114416,"twenty":-3.04097,"median":-0.21928,"eighty":1.575586,"marketCap":52253346},{"date":"2020-05-29","current":-0.122977,"twenty":-3.04097,"median":-0.217481,"eighty":1.575586,"marketCap":56163460},{"date":"2020-06-05","current":-0.140101,"twenty":-2.99804,"median":-0.21582,"eighty":1.575586,"marketCap":63983689},{"date":"2020-06-12","current":-0.129204,"twenty":-2.97896,"median":-0.213947,"eighty":1.575586,"marketCap":59007180},{"date":"2020-06-19","current":-0.105075,"twenty":-2.950339,"median":-0.211094,"eighty":1.575586,"marketCap":47987766},{"date":"2020-06-26","current":-0.101962,"twenty":-2.890333,"median":-0.207997,"eighty":1.575586,"marketCap":46565907},{"date":"2020-07-02","current":-0.101184,"twenty":-2.816779,"median":-0.205444,"eighty":1.575586,"marketCap":46210442},{"date":"2020-07-10","current":-0.101962,"twenty":-2.816779,"median":-0.199194,"eighty":1.575586,"marketCap":46565907},{"date":"2020-07-17","current":-0.100405,"twenty":-2.735737,"median":-0.190689,"eighty":1.575586,"marketCap":45854977},{"date":"2020-07-24","current":-0.105854,"twenty":-2.735737,"median":-0.182973,"eighty":1.575586,"marketCap":48343231},{"date":"2020-07-31","current":-0.101184,"twenty":-2.734988,"median":-0.181048,"eighty":1.575586,"marketCap":46210442},{"date":"2020-08-07","current":-0.091762,"twenty":-2.734988,"median":-0.178762,"eighty":1.575586,"marketCap":60489194},{"date":"2020-08-14","current":-0.100399,"twenty":-2.701686,"median":-0.177271,"eighty":1.575586,"marketCap":66182294},{"date":"2020-08-21","current":-0.085285,"twenty":-2.701686,"median":-0.176827,"eighty":1.575586,"marketCap":56219368},{"date":"2020-08-28","current":-0.086365,"twenty":-2.701686,"median":-0.17579,"eighty":1.575586,"marketCap":56931006},{"date":"2020-09-04","current":-0.09716,"twenty":-2.699251,"median":-0.173865,"eighty":1.575586,"marketCap":64047382},{"date":"2020-09-11","current":-0.087984,"twenty":-2.699251,"median":-0.172434,"eighty":1.575586,"marketCap":57998462},{"date":"2020-09-18","current":-0.101479,"twenty":-2.699251,"median":-0.171273,"eighty":1.575586,"marketCap":66893932},{"date":"2020-09-25","current":-0.089603,"twenty":-2.699251,"median":-0.169269,"eighty":1.575586,"marketCap":59065919},{"date":"2020-10-02","current":-0.086904,"twenty":-2.699251,"median":-0.166757,"eighty":1.575586,"marketCap":57286825},{"date":"2020-10-09","current":-0.102558,"twenty":-2.680658,"median":-0.163869,"eighty":1.575586,"marketCap":67605570},{"date":"2020-10-16","current":-0.089064,"twenty":-2.66132,"median":-0.161869,"eighty":1.575586,"marketCap":58710100},{"date":"2020-10-23","current":-0.103638,"twenty":-2.66132,"median":-0.160018,"eighty":1.575586,"marketCap":68317207},{"date":"2020-10-30","current":-0.092842,"twenty":-2.66132,"median":-0.157438,"eighty":1.575586,"marketCap":61200831},{"date":"2020-11-06","current":-0.143096,"twenty":-2.66132,"median":-0.155575,"eighty":1.55101,"marketCap":75317355},{"date":"2020-11-13","current":-0.179718,"twenty":-2.66132,"median":-0.157575,"eighty":1.488204,"marketCap":94592886},{"date":"2020-11-20","current":-0.181753,"twenty":-2.66132,"median":-0.160907,"eighty":1.442693,"marketCap":95663749},{"date":"2020-11-27","current":-0.195316,"twenty":-2.66132,"median":-0.161869,"eighty":1.390651,"marketCap":102802835},{"date":"2020-12-04","current":-0.199385,"twenty":-2.66132,"median":-0.163276,"eighty":1.276397,"marketCap":104944561},{"date":"2020-12-11","current":-0.210915,"twenty":-2.66132,"median":-0.166106,"eighty":1.218547,"marketCap":111012784},{"date":"2020-12-18","current":-0.213627,"twenty":-2.66132,"median":-0.167688,"eighty":1.104442,"marketCap":112440601},{"date":"2020-12-24","current":-0.214305,"twenty":-2.66132,"median":-0.170015,"eighty":0.955137,"marketCap":112797555},{"date":"2020-12-31","current":-0.210236,"twenty":-2.66132,"median":-0.171422,"eighty":0.844957,"marketCap":110655829},{"date":"2021-01-08","current":-0.238042,"twenty":-2.66132,"median":-0.172458,"eighty":0.774908,"marketCap":125290955},{"date":"2021-01-15","current":-0.339769,"twenty":-2.66132,"median":-0.174458,"eighty":0.729304,"marketCap":178834099},{"date":"2021-01-22","current":-0.318746,"twenty":-2.66132,"median":-0.175864,"eighty":0.623137,"marketCap":167768516},{"date":"2021-01-29","current":-0.286193,"twenty":-2.66132,"median":-0.176975,"eighty":0.614746,"marketCap":150634710},{"date":"2021-02-05","current":-0.32078,"twenty":-2.66132,"median":-0.177345,"eighty":0.540199,"marketCap":168839379},{"date":"2021-02-12","current":-0.357402,"twenty":-2.66132,"median":-0.178762,"eighty":0.299811,"marketCap":188114910},{"date":"2021-02-19","current":-0.356046,"twenty":-2.66132,"median":-0.180096,"eighty":0.293846,"marketCap":187401002},{"date":"2021-02-26","current":-0.339769,"twenty":-2.66132,"median":-0.18127,"eighty":0.278675,"marketCap":178834099},{"date":"2021-03-05","current":-0.52729,"twenty":-3.043973,"median":-0.183041,"eighty":0.257822,"marketCap":146245483},{"date":"2021-03-12","current":-0.577941,"twenty":-3.043973,"median":-0.185822,"eighty":0.237224,"marketCap":160293694},{"date":"2021-03-19","current":-0.519498,"twenty":-3.043973,"median":-0.188879,"eighty":0.223871,"marketCap":144084220},{"date":"2021-03-26","current":-0.520796,"twenty":-2.66132,"median":-0.195316,"eighty":0.173892,"marketCap":144444430},{"date":"2021-04-01","current":-0.520796,"twenty":-2.66132,"median":-0.198029,"eighty":-0.002773,"marketCap":144444430},{"date":"2021-04-09","current":-0.483133,"twenty":-3.043973,"median":-0.202085,"eighty":-0.003094,"marketCap":133998324},{"date":"2021-04-16","current":-0.486815,"twenty":-3.043973,"median":-0.204788,"eighty":-0.003161,"marketCap":135019521},{"date":"2021-04-23","current":-0.515682,"twenty":-3.043973,"median":-0.207878,"eighty":-0.003276,"marketCap":143026069},{"date":"2021-04-30","current":-0.532741,"twenty":-3.043973,"median":-0.210329,"eighty":-0.004577,"marketCap":147757212},{"date":"2021-05-07","current":-0.590476,"twenty":-3.043973,"median":-0.21151,"eighty":-0.008134,"marketCap":163770309},{"date":"2021-05-14","current":-0.803793,"twenty":-3.043973,"median":-0.213835,"eighty":-0.009471,"marketCap":184583018},{"date":"2021-05-21","current":-0.814891,"twenty":-3.043973,"median":-0.214877,"eighty":-0.009471,"marketCap":187131501},{"date":"2021-05-28","current":-0.841842,"twenty":-3.043973,"median":-0.216246,"eighty":-0.009471,"marketCap":193320676},{"date":"2021-06-04","current":-1.008308,"twenty":-3.043973,"median":-0.21745,"eighty":-0.009471,"marketCap":231547928},{"date":"2021-06-11","current":-1.009894,"twenty":-3.043973,"median":-0.219342,"eighty":-0.009471,"marketCap":231911997},{"date":"2021-06-18","current":-0.959161,"twenty":-3.043973,"median":-0.219969,"eighty":-0.009471,"marketCap":220261787},{"date":"2021-06-25","current":-1.030504,"twenty":-3.043973,"median":-0.220653,"eighty":-0.009471,"marketCap":236644895},{"date":"2021-07-02","current":-0.992454,"twenty":-3.043973,"median":-0.221995,"eighty":-0.009471,"marketCap":227907237},{"date":"2021-07-09","current":-0.919526,"twenty":-3.043973,"median":-0.223126,"eighty":-0.009471,"marketCap":211160060},{"date":"2021-07-16","current":-0.806964,"twenty":-3.043973,"median":-0.224421,"eighty":-0.009471,"marketCap":185311156},{"date":"2021-07-23","current":-0.883062,"twenty":-3.043973,"median":-0.225106,"eighty":-0.009471,"marketCap":202786471},{"date":"2021-07-30","current":-0.948064,"twenty":-3.043973,"median":-0.226177,"eighty":-0.009582,"marketCap":217713303},{"date":"2021-08-06","current":-1.059041,"twenty":-3.043973,"median":-0.227027,"eighty":-0.010935,"marketCap":243198138},{"date":"2021-08-13","current":133.685349,"twenty":-3.043973,"median":-0.227203,"eighty":-0.011807,"marketCap":319641669},{"date":"2021-08-20","current":130.327954,"twenty":-3.043973,"median":-0.227203,"eighty":-0.011807,"marketCap":311614138},{"date":"2021-08-27","current":146.199274,"twenty":-3.043973,"median":-0.227203,"eighty":-0.011807,"marketCap":349562464},{"date":"2021-09-03","current":153.524499,"twenty":-3.043973,"median":-0.227203,"eighty":-0.004577,"marketCap":367077076},{"date":"2021-09-10","current":156.729284,"twenty":-3.043973,"median":-0.227203,"eighty":-0.003197,"marketCap":374739719},{"date":"2021-09-17","current":174.43191,"twenty":-3.043973,"median":-0.227203,"eighty":-0.002948,"marketCap":417066698},{"date":"2021-09-24","current":176.568434,"twenty":-3.043973,"median":-0.227203,"eighty":-0.002766,"marketCap":422175126},{"date":"2021-10-01","current":207.395421,"twenty":-3.043973,"median":-0.227203,"eighty":0.222451,"marketCap":495882452},{"date":"2021-10-08","current":208.311074,"twenty":-2.287415,"median":-0.227027,"eighty":0.23211,"marketCap":498071778},{"date":"2021-10-15","current":175.80539,"twenty":-2.287415,"median":-0.227027,"eighty":0.253958,"marketCap":420350688},{"date":"2021-10-22","current":182.062353,"twenty":-2.287415,"median":-0.226511,"eighty":0.276345,"marketCap":435311085},{"date":"2021-10-29","current":195.339322,"twenty":-1.909137,"median":-0.225208,"eighty":0.284016,"marketCap":467056320},{"date":"2021-11-05","current":199.917588,"twenty":-1.909137,"median":-0.224657,"eighty":0.299328,"marketCap":478002952},{"date":"2021-11-12","current":6.485694,"twenty":-1.909137,"median":-0.224541,"eighty":0.306317,"marketCap":517162779},{"date":"2021-11-19","current":5.375696,"twenty":-1.909137,"median":-0.224541,"eighty":3.265836,"marketCap":428652600},{"date":"2021-11-26","current":5.462844,"twenty":-1.909137,"median":-0.224541,"eighty":3.318245,"marketCap":435601747},{"date":"2021-12-03","current":4.495036,"twenty":-1.909137,"median":-0.224541,"eighty":3.372152,"marketCap":358429649},{"date":"2021-12-10","current":4.751895,"twenty":-1.909137,"median":-0.224541,"eighty":3.397608,"marketCap":378911343},{"date":"2021-12-17","current":4.605118,"twenty":-1.909137,"median":-0.224541,"eighty":3.417074,"marketCap":367207518},{"date":"2021-12-23","current":4.903258,"twenty":-1.909137,"median":-0.224541,"eighty":3.453011,"marketCap":390980913},{"date":"2021-12-31","current":4.797763,"twenty":-1.909137,"median":-0.224541,"eighty":3.509913,"marketCap":382568788},{"date":"2022-01-07","current":4.994994,"twenty":-1.530858,"median":-0.22451,"eighty":3.590772,"marketCap":398295804},{"date":"2022-01-14","current":5.251853,"twenty":-1.530858,"median":-0.22451,"eighty":3.662647,"marketCap":418777498},{"date":"2022-01-21","current":4.563837,"twenty":-1.530858,"median":-0.22451,"eighty":3.737517,"marketCap":363915817},{"date":"2022-01-28","current":5.132597,"twenty":-1.530858,"median":-0.22451,"eighty":3.821373,"marketCap":409268140},{"date":"2022-02-04","current":5.673836,"twenty":-1.530858,"median":-0.22451,"eighty":4.090905,"marketCap":452425995},{"date":"2022-02-11","current":5.614208,"twenty":-1.530858,"median":-0.22451,"eighty":4.263106,"marketCap":447671316},{"date":"2022-02-18","current":5.39863,"twenty":-1.530858,"median":-0.22451,"eighty":4.434756,"marketCap":430481323},{"date":"2022-02-25","current":5.98115,"twenty":-1.530858,"median":-0.22451,"eighty":4.513383,"marketCap":476930880},{"date":"2022-03-04","current":7.178297,"twenty":-1.530858,"median":-0.224421,"eighty":4.596862,"marketCap":572390205},{"date":"2022-03-11","current":5.06258,"twenty":-1.530858,"median":-0.224161,"eighty":4.650986,"marketCap":590995441},{"date":"2022-03-18","current":4.456828,"twenty":-1.530858,"median":-0.224161,"eighty":4.691727,"marketCap":520281169},{"date":"2022-03-25","current":5.395273,"twenty":-1.530858,"median":-0.224161,"eighty":4.743638,"marketCap":629833331},{"date":"2022-04-01","current":5.263451,"twenty":-1.530858,"median":-0.223126,"eighty":4.790424,"marketCap":614444733},{"date":"2022-04-08","current":5.464322,"twenty":-1.530858,"median":-0.220953,"eighty":4.875738,"marketCap":637894025},{"date":"2022-04-14","current":5.903728,"twenty":-1.530858,"median":-0.219822,"eighty":4.907845,"marketCap":689189352},{"date":"2022-04-22","current":5.583589,"twenty":-1.530858,"median":-0.216912,"eighty":4.999086,"marketCap":651817043},{"date":"2022-04-29","current":5.833099,"twenty":-1.530858,"median":-0.214099,"eighty":5.057558,"marketCap":680944369},{"date":"2022-05-06","current":6.2554,"twenty":-1.530858,"median":-0.21142,"eighty":5.136266,"marketCap":728247452},{"date":"2022-05-13","current":5.776639,"twenty":-1.530858,"median":-0.20888,"eighty":5.227332,"marketCap":672510487},{"date":"2022-05-20","current":6.274299,"twenty":-1.530858,"median":-0.204788,"eighty":5.268229,"marketCap":730447595},{"date":"2022-05-27","current":7.776729,"twenty":-1.530858,"median":-0.202085,"eighty":5.326158,"marketCap":905358992},{"date":"2022-06-03","current":8.466524,"twenty":-1.530858,"median":-0.199194,"eighty":5.38328,"marketCap":985664225},{"date":"2022-06-10","current":8.463374,"twenty":-1.530858,"median":-0.195316,"eighty":5.455506,"marketCap":985297534},{"date":"2022-06-17","current":6.044367,"twenty":-1.530858,"median":-0.187522,"eighty":5.488941,"marketCap":703679184},{"date":"2022-06-24","current":5.033298,"twenty":-1.909137,"median":-0.186462,"eighty":5.50596,"marketCap":585971514},{"date":"2022-07-01","current":5.014399,"twenty":-1.909137,"median":-0.183109,"eighty":5.50596,"marketCap":583771371},{"date":"2022-07-08","current":5.080544,"twenty":-1.909137,"median":-0.181075,"eighty":5.50596,"marketCap":591471873},{"date":"2022-07-15","current":5.017549,"twenty":-1.909137,"median":-0.170852,"eighty":5.50596,"marketCap":584138062},{"date":"2022-07-22","current":5.341973,"twenty":-1.909137,"median":-0.166897,"eighty":5.512382,"marketCap":621907189},{"date":"2022-07-29","current":5.899479,"twenty":-1.909137,"median":-0.162764,"eighty":5.577514,"marketCap":686811418},{"date":"2022-08-05","current":4.367858,"twenty":-1.909137,"median":-0.155064,"eighty":5.579944,"marketCap":649321384},{"date":"2022-08-12","current":4.750354,"twenty":-1.909137,"median":-0.143096,"eighty":5.579944,"marketCap":706182862},{"date":"2022-08-19","current":5.061286,"twenty":-1.909137,"median":-0.132121,"eighty":5.579944,"marketCap":752405740},{"date":"2022-08-26","current":5.39196,"twenty":-1.909137,"median":-0.126091,"eighty":5.579944,"marketCap":801563404},{"date":"2022-09-02","current":4.972448,"twenty":-1.909137,"median":-0.122977,"eighty":5.579944,"marketCap":739199203},{"date":"2022-09-09","current":4.762692,"twenty":-1.909137,"median":-0.122199,"eighty":5.579944,"marketCap":708017103},{"date":"2022-09-16","current":4.382664,"twenty":-1.909137,"median":-0.118307,"eighty":5.579944,"marketCap":651522474},{"date":"2022-09-23","current":3.741058,"twenty":-1.909137,"median":-0.116298,"eighty":5.579944,"marketCap":556141931},{"date":"2022-09-30","current":4.024845,"twenty":-1.909137,"median":-0.107956,"eighty":5.579944,"marketCap":598329479},{"date":"2022-10-07","current":4.663984,"twenty":-1.909137,"median":-0.105075,"eighty":5.579944,"marketCap":693343173},{"date":"2022-10-14","current":4.395003,"twenty":-1.909137,"median":-0.103638,"eighty":5.579944,"marketCap":653356715},{"date":"2022-10-21","current":4.481373,"twenty":-1.909137,"median":-0.102558,"eighty":5.579944,"marketCap":666196403},{"date":"2022-10-28","current":4.508518,"twenty":-1.909137,"median":-0.101479,"eighty":5.579944,"marketCap":670231734},{"date":"2022-11-04","current":4.403711,"twenty":-1.909137,"median":-0.100939,"eighty":5.579944,"marketCap":765298881},{"date":"2022-11-11","current":4.325338,"twenty":-1.909137,"median":-0.100399,"eighty":5.579944,"marketCap":751678843},{"date":"2022-11-18","current":4.149528,"twenty":-1.909137,"median":-0.09807,"eighty":5.579944,"marketCap":721125785},{"date":"2022-11-25","current":4.289329,"twenty":-1.909137,"median":-0.0977,"eighty":5.579944,"marketCap":745420988},{"date":"2022-12-02","current":4.289329,"twenty":-1.909137,"median":-0.096514,"eighty":5.579944,"marketCap":745420988},{"date":"2022-12-09","current":3.672936,"twenty":-1.909137,"median":-0.095001,"eighty":5.579944,"marketCap":638301231},{"date":"2022-12-16","current":3.651754,"twenty":-1.909137,"median":-0.094461,"eighty":5.579944,"marketCap":634620140},{"date":"2022-12-23","current":3.679291,"twenty":-1.909137,"median":-0.092842,"eighty":5.579944,"marketCap":639405558},{"date":"2022-12-30","current":3.607272,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":626889848},{"date":"2023-01-06","current":3.497127,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":607748173},{"date":"2023-01-13","current":3.651754,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":634620140},{"date":"2023-01-20","current":3.677173,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":639037449},{"date":"2023-01-27","current":3.458999,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":601122209},{"date":"2023-02-03","current":3.232353,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":561734532},{"date":"2023-02-10","current":3.374272,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":586397844},{"date":"2023-02-17","current":3.094671,"twenty":-1.909137,"median":-0.092302,"eighty":5.579944,"marketCap":537807438},{"date":"2023-02-24","current":3.069253,"twenty":-1.909137,"median":-0.092302,"eighty":5.552745,"marketCap":533390129},{"date":"2023-03-03","current":3.300135,"twenty":-1.909137,"median":-0.092302,"eighty":5.50596,"marketCap":573514024},{"date":"2023-03-10","current":2.923098,"twenty":-1.909137,"median":-0.092302,"eighty":5.476483,"marketCap":507990599},{"date":"2023-03-17","current":2.108279,"twenty":-1.909137,"median":-0.092302,"eighty":5.463435,"marketCap":510557771},{"date":"2023-03-24","current":2.123501,"twenty":-1.909137,"median":-0.092302,"eighty":5.422256,"marketCap":514244109},{"date":"2023-03-31","current":2.193524,"twenty":-1.530858,"median":-0.092032,"eighty":5.382618,"marketCap":531201262},{"date":"2023-04-06","current":2.330524,"twenty":-1.530858,"median":-0.092032,"eighty":5.343213,"marketCap":564378301},{"date":"2023-04-14","current":2.350313,"twenty":-1.909137,"median":-0.092302,"eighty":5.280538,"marketCap":569170540},{"date":"2023-04-21","current":2.223968,"twenty":-1.909137,"median":-0.092302,"eighty":5.260602,"marketCap":538573937},{"date":"2023-04-28","current":2.115524,"twenty":-1.909137,"median":-0.092302,"eighty":5.201307,"marketCap":512312287},{"date":"2023-05-05","current":1.996726,"twenty":-1.909137,"median":-0.092302,"eighty":5.168743,"marketCap":483543130},{"date":"2023-05-12","current":2.281272,"twenty":-1.036156,"median":-0.091762,"eighty":5.168743,"marketCap":527434536},{"date":"2023-05-19","current":2.75986,"twenty":-1.024459,"median":-0.090143,"eighty":5.168743,"marketCap":638085138},{"date":"2023-05-26","current":2.321154,"twenty":-1.01264,"median":-0.089603,"eighty":5.168743,"marketCap":536655419},{"date":"2023-06-02","current":2.211079,"twenty":-1.007179,"median":-0.089381,"eighty":5.168743,"marketCap":511205781},{"date":"2023-06-08","current":2.412086,"twenty":-1.002776,"median":-0.088524,"eighty":5.168743,"marketCap":557679034},{"date":"2023-06-16","current":2.281272,"twenty":-0.996257,"median":-0.087444,"eighty":5.170762,"marketCap":527434536},{"date":"2023-06-23","current":2.212674,"twenty":-0.992137,"median":-0.086365,"eighty":5.172782,"marketCap":511574616},{"date":"2023-06-30","current":2.432825,"twenty":-0.971844,"median":-0.085356,"eighty":5.174801,"marketCap":562473893},{"date":"2023-07-07","current":2.404109,"twenty":-0.965101,"median":-0.083844,"eighty":5.175295,"marketCap":555834857},{"date":"2023-07-14","current":2.552472,"twenty":-0.948698,"median":-0.071339,"eighty":5.175295,"marketCap":590136544},{"date":"2023-07-21","current":2.534923,"twenty":-0.932417,"median":-0.066142,"eighty":5.175295,"marketCap":586079355},{"date":"2023-07-28","current":2.616283,"twenty":-0.919526,"median":-0.064441,"eighty":5.175295,"marketCap":604889957},{"date":"2023-08-04","current":3.054488,"twenty":-0.910289,"median":1.988024,"eighty":5.175295,"marketCap":608903040},{"date":"2023-08-11","current":3.08041,"twenty":-0.902047,"median":2.083924,"eighty":5.175295,"marketCap":614070574},{"date":"2023-08-18","current":2.965497,"twenty":-0.888634,"median":2.123501,"eighty":5.175295,"marketCap":591163008},{"date":"2023-08-25","current":2.859852,"twenty":-0.875322,"median":2.155243,"eighty":5.175295,"marketCap":570102825},{"date":"2023-09-01","current":2.963644,"twenty":-0.843527,"median":2.163079,"eighty":5.175295,"marketCap":590793531},{"date":"2023-09-08","current":3.008126,"twenty":-0.838989,"median":2.183959,"eighty":5.175295,"marketCap":599660976},{"date":"2023-09-15","current":3.00998,"twenty":-0.830972,"median":2.209483,"eighty":5.175295,"marketCap":600030453},{"date":"2023-09-22","current":2.824636,"twenty":-0.82472,"median":2.223968,"eighty":5.175295,"marketCap":563082765},{"date":"2023-09-29","current":2.930282,"twenty":-0.808354,"median":2.258979,"eighty":5.175295,"marketCap":584142947},{"date":"2023-10-06","current":2.720844,"twenty":-0.779061,"median":2.281272,"eighty":5.175295,"marketCap":542392059},{"date":"2023-10-13","current":2.909894,"twenty":-0.709616,"median":2.322913,"eighty":5.175295,"marketCap":580078701},{"date":"2023-10-20","current":3.047049,"twenty":-0.674037,"median":2.333568,"eighty":5.175295,"marketCap":607419990},{"date":"2023-10-27","current":2.94511,"twenty":-0.64577,"median":2.353357,"eighty":5.177269,"marketCap":587098762},{"date":"2023-11-03","current":2.967351,"twenty":-0.611654,"median":2.403591,"eighty":5.177269,"marketCap":591532484},{"date":"2023-11-10","current":3.21558,"twenty":-0.589722,"median":2.432825,"eighty":5.177269,"marketCap":528294083},{"date":"2023-11-17","current":3.238146,"twenty":-0.574045,"median":2.474302,"eighty":5.177269,"marketCap":532001410},{"date":"2023-11-24","current":3.271994,"twenty":-0.567551,"median":2.534923,"eighty":5.177269,"marketCap":537562400},{"date":"2023-12-01","current":3.116292,"twenty":-0.552423,"median":2.603521,"eighty":5.177269,"marketCap":511981844},{"date":"2023-12-08","current":3.039569,"twenty":-0.540018,"median":2.650582,"eighty":5.176775,"marketCap":499376933},{"date":"2023-12-15","current":3.134344,"twenty":-0.525991,"median":2.722803,"eighty":5.176775,"marketCap":514947706},{"date":"2023-12-22","current":3.174962,"twenty":-0.514043,"median":2.780154,"eighty":5.176775,"marketCap":521620894},{"date":"2023-12-29","current":3.132088,"twenty":-0.509108,"median":2.824636,"eighty":5.177269,"marketCap":514576973},{"date":"2024-01-05","current":3.09147,"twenty":-0.506571,"median":2.854539,"eighty":5.177452,"marketCap":507903785},{"date":"2024-01-12","current":3.030543,"twenty":-0.492979,"median":2.875606,"eighty":5.177452,"marketCap":497894002},{"date":"2024-01-19","current":3.152397,"twenty":-0.485385,"median":2.902481,"eighty":5.177636,"marketCap":517913567},{"date":"2024-01-26","current":3.271994,"twenty":-0.475072,"median":2.921015,"eighty":5.177452,"marketCap":537562400},{"date":"2024-02-02","current":3.278763,"twenty":-0.367032,"median":2.930282,"eighty":5.177452,"marketCap":538674598},{"date":"2024-02-09","current":2.798119,"twenty":-0.357402,"median":2.930282,"eighty":5.177452,"marketCap":459708535},{"date":"2024-02-16","current":2.922229,"twenty":-0.347636,"median":2.930282,"eighty":5.177452,"marketCap":480098833},{"date":"2024-02-23","current":2.928999,"twenty":-0.340583,"median":2.931209,"eighty":5.177452,"marketCap":481211031},{"date":"2024-03-01","current":2.942538,"twenty":-0.324849,"median":2.933989,"eighty":5.177269,"marketCap":483435427},{"date":"2024-03-08","current":3.077931,"twenty":-0.308573,"median":2.937696,"eighty":5.177269,"marketCap":505679389},{"date":"2024-03-15","current":8.394693,"twenty":-0.286193,"median":2.947051,"eighty":5.233506,"marketCap":510875813},{"date":"2024-03-22","current":8.692981,"twenty":-0.254318,"median":2.965497,"eighty":5.26659,"marketCap":529028760},{"date":"2024-03-28","current":8.832994,"twenty":-0.233295,"median":2.969204,"eighty":5.282283,"marketCap":537549532},{"date":"2024-04-05","current":9.131283,"twenty":-0.21512,"median":3.005346,"eighty":5.343213,"marketCap":555702480},{"date":"2024-04-12","current":9.173895,"twenty":-0.210372,"median":3.015541,"eighty":5.392623,"marketCap":558295758},{"date":"2024-04-19","current":8.717331,"twenty":-0.203047,"median":3.02876,"eighty":5.44914,"marketCap":530510634},{"date":"2024-04-26","current":8.905871,"twenty":-0.195316,"median":3.047049,"eighty":5.464813,"marketCap":541984599},{"date":"2024-05-03","current":8.284531,"twenty":-0.185822,"median":3.054488,"eighty":5.477412,"marketCap":504171720},{"date":"2024-05-10","current":10.439414,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":503430291},{"date":"2024-05-17","current":10.316416,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":497498859},{"date":"2024-05-24","current":10.36254,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":499723146},{"date":"2024-05-31","current":10.477851,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":505283863},{"date":"2024-06-07","current":10.031985,"twenty":-0.185128,"median":3.057622,"eighty":5.504125,"marketCap":483782422},{"date":"2024-06-14","current":9.993548,"twenty":-0.185267,"median":3.057622,"eighty":5.500456,"marketCap":481928850},{"date":"2024-06-21","current":10.039672,"twenty":-0.185406,"median":3.057622,"eighty":5.491591,"marketCap":484153137},{"date":"2024-06-28","current":9.924362,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":478592419},{"date":"2024-07-05","current":10.055047,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":484894566},{"date":"2024-07-12","current":10.024297,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":483411708},{"date":"2024-07-15","current":10.108858,"twenty":-0.185822,"median":3.055402,"eighty":5.477412,"marketCap":487489567},{"date":"2024-08-02","current":10.01661,"twenty":-0.186229,"median":3.041488,"eighty":5.43,"marketCap":483040993},{"date":"2024-08-09","current":11.621635,"twenty":-0.186229,"median":3.041488,"eighty":5.450163,"marketCap":469293243},{"date":"2024-08-16","current":12.062963,"twenty":-0.186229,"median":3.041488,"eighty":5.466384,"marketCap":487114505},{"date":"2024-08-23","current":12.127323,"twenty":-0.186229,"median":3.041488,"eighty":5.48274,"marketCap":489713439},{"date":"2024-08-30","current":12.347987,"twenty":-0.186229,"median":3.041488,"eighty":5.514296,"marketCap":498624070},{"date":"2024-09-06","current":11.391777,"twenty":-0.186229,"median":3.041488,"eighty":5.57201,"marketCap":460011335},{"date":"2024-09-13","current":10.830922,"twenty":-0.186229,"median":3.041488,"eighty":5.599109,"marketCap":437363481},{"date":"2024-09-20","current":11.253862,"twenty":-0.186229,"median":3.041488,"eighty":5.638997,"marketCap":454442191},{"date":"2024-09-27","current":10.683813,"twenty":-0.186229,"median":3.041488,"eighty":5.705563,"marketCap":431423060},{"date":"2024-10-04","current":11.796327,"twenty":-0.186229,"median":3.041488,"eighty":5.810515,"marketCap":476347492},{"date":"2024-10-11","current":11.373388,"twenty":-0.186229,"median":3.041488,"eighty":5.902028,"marketCap":459268783},{"date":"2024-10-18","current":10.849311,"twenty":-0.186229,"median":3.041488,"eighty":5.986654,"marketCap":438106034},{"date":"2024-10-25","current":10.371206,"twenty":-0.186229,"median":3.041488,"eighty":6.158999,"marketCap":418799666},{"date":"2024-10-31","current":10.279263,"twenty":-0.186229,"median":3.041488,"eighty":6.2554,"marketCap":415086903},{"date":"2024-11-08","current":9.658709,"twenty":-0.186364,"median":3.040529,"eighty":6.338506,"marketCap":455842770},{"date":"2024-11-15","current":9.251565,"twenty":-0.185683,"median":3.047049,"eighty":6.476802,"marketCap":436627626},{"date":"2024-11-22","current":9.251565,"twenty":-0.181075,"median":3.056969,"eighty":6.574785,"marketCap":436627626},{"date":"2024-11-29","current":9.235818,"twenty":-0.177176,"median":3.070198,"eighty":6.933226,"marketCap":435884430},{"date":"2024-12-06","current":8.802766,"twenty":-0.167619,"median":3.080127,"eighty":7.38553,"marketCap":415446541},{"date":"2024-12-13","current":8.912997,"twenty":-0.164235,"median":3.088696,"eighty":7.999101,"marketCap":420648913},{"date":"2024-12-20","current":8.267356,"twenty":-0.15664,"median":3.111918,"eighty":8.279954,"marketCap":390177879},{"date":"2024-12-27","current":8.582303,"twenty":-0.148102,"median":3.125881,"eighty":8.3357,"marketCap":405041798},{"date":"2025-01-03","current":9.456281,"twenty":-0.139634,"median":3.133216,"eighty":8.412503,"marketCap":446289173},{"date":"2025-01-10","current":9.621628,"twenty":-0.131539,"median":3.139153,"eighty":8.463374,"marketCap":454092731},{"date":"2025-01-17","current":9.928701,"twenty":-0.126091,"median":3.15691,"eighty":8.522531,"marketCap":468585052},{"date":"2025-01-24","current":9.700365,"twenty":-0.122977,"median":3.16669,"eighty":8.626019,"marketCap":457808711},{"date":"2025-01-31","current":9.566512,"twenty":-0.121996,"median":3.190758,"eighty":8.686894,"marketCap":451491545},{"date":"2025-02-07","current":9.330302,"twenty":-0.11788,"median":3.219644,"eighty":8.802766,"marketCap":440343606},{"date":"2025-02-14","current":9.527144,"twenty":-0.115194,"median":3.232353,"eighty":8.857882,"marketCap":449633555},{"date":"2025-02-21","current":9.842091,"twenty":-0.107956,"median":3.265224,"eighty":8.881503,"marketCap":464497475},{"date":"2025-02-28","current":9.220071,"twenty":-0.105075,"median":3.278763,"eighty":8.930237,"marketCap":435141234},{"date":"2025-03-07","current":8.621672,"twenty":-0.103543,"median":3.290923,"eighty":8.933445,"marketCap":406899788},{"date":"2025-03-14","current":6.607418,"twenty":-0.103543,"median":3.309215,"eighty":8.933445,"marketCap":416174831},{"date":"2025-03-21","current":6.87831,"twenty":-0.103543,"median":3.353299,"eighty":8.933445,"marketCap":433237258},{"date":"2025-03-28","current":6.801754,"twenty":-0.103543,"median":3.420872,"eighty":8.933445,"marketCap":428415268},{"date":"2025-04-04","current":6.224635,"twenty":-0.103543,"median":3.504541,"eighty":8.933445,"marketCap":392064881},{"date":"2025-04-11","current":5.417847,"twenty":-0.103519,"median":3.550081,"eighty":8.932686,"marketCap":341248525},{"date":"2025-04-17","current":5.529738,"twenty":-0.103519,"median":3.578189,"eighty":8.932686,"marketCap":348296049},{"date":"2025-04-25","current":5.512071,"twenty":-0.102594,"median":3.627395,"eighty":8.933445,"marketCap":347183282},{"date":"2025-05-01","current":5.364847,"twenty":-0.101479,"median":3.665522,"eighty":8.933445,"marketCap":337910224}],"updateTime":1746178750572}}}